Bio Pharma Dive
JANUARY 11, 2024
Investors and executives interviewed by BioPharma Dive at J.P. Morgan say new companies have to be leaner, hire more conservatively and focus on their first medicines quickly.
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 11, 2024
Researchers have identified an entirely new class of antibiotic that can kill bacteria that are resistant to most current drugs. Zosurabalpin is highly effective against the bacterium carbapenem-resistant Acinetobacter baumannii (Crab), which is classified as a “priority 1” pathogen by the World Health Organization due to its growing presence in hospitals.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 11, 2024
Though the number of financings from private investors is down year over year, the size of those rounds has remained high, especially for drugmakers with human data in hand.
Rethinking Clinical Trials
JANUARY 11, 2024
In a new article from the NIH Pragmatic Trials Collaboratory, the BeatPain Utah study team describes the "implementation mapping" they used to plan for trial implementation. The comprehensive, systematic approach enabled the team to craft an implementation plan for a complex telehealth intervention and to identify outcomes for evaluating the success of the implementation strategies.
Bio Pharma Dive
JANUARY 11, 2024
As a result of the planned consultation, Eisai now expects an approval decision on Leqembi in Europe by the end of June, rather than March.
Pharma Mirror
JANUARY 11, 2024
Embarking on a career as a substance misuse counselor is both a noble and challenging path. This role demands a deep understanding of psychological principles, empathy, and the determination to support others through their recovery journey. Keep reading to discover the steps required to build a successful career in this field. Understanding the Role of a Substance Addiction Counselor Substance addiction counselors are professionals who specialize in helping people overcome addictions to drugs, a
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 11, 2024
Home Editorial Services Interview Q&A Chronicle Specials Pharma Mart ePharmail Archives Join Pharma | Login Home > TopNews you can get e-magazine links on WhatsApp.
Pharmaceutical Technology
JANUARY 11, 2024
BridgeBio submitted the NDA with US FDA for the TTR stabiliser in December 2023 and plans to engage with other regulatory bodies this year.
pharmaphorum
JANUARY 11, 2024
Generative AI is revolutionising the pharmaceutical industry, accelerating the speed to market for new drugs. Learn how regulatory processes, R&D, and clinical trials are being impacted by this innovative technology.
Pharmaceutical Technology
JANUARY 11, 2024
Though not approved in the US, Laboratoires Delbert’s extencilline will be the available alternative to Pfizer’s Bicillin L-A.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Fierce Pharma
JANUARY 11, 2024
Dermavant’s topical cream Vtama, already on the market for plaque psoriasis as a steroid-free treatment, is compiling impressive data in pursuit of an FDA approval in atopic dermatitis (AD). | Dermavant’s topical cream Vtama, already on the market for plaque psoriasis as a steroid-free treatment, is compiling impressive data in pursuit of an FDA approval in atopic dermatitis (AD).
Pharmaceutical Technology
JANUARY 11, 2024
Evotec has announced a collaboration with the Crohn's & Colitis Foundation to advance drug discovery and develop new therapies for IBD.
pharmaphorum
JANUARY 11, 2024
The FDA is overseeing significant changes in R&D IT as it shifts towards advanced modalities and biologics. This includes the emergence of CRISPR-Cas9 gene editing technology and its potential impact on diseases like sickle cell anaemia. Learn more about these exciting developments in this article.
Pharmaceutical Technology
JANUARY 11, 2024
Expanded patient groups at risk of progression to severe Covid-19 will be eligible for Pfizer’s antiviral pill.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Drug Discovery World
JANUARY 11, 2024
Verge Genomics has initiated a Phase Ib proof-of-concept study for the treatment of sporadic and familial forms of amyotrophic lateral sclerosis (ALS) with VRG50635. VRG50635 is a small molecule PIKfyve inhibitor and is reportedly one of the first drugs to enter clinical trials that was entirely discovered and developed using an AI-enabled platform.
Pharmaceutical Technology
JANUARY 11, 2024
GSK has gained approval from the China National Medical Products Administration for Nucala (mepolizumab) for severe eosinophilic asthma.
XTalks
JANUARY 11, 2024
In the dynamic world of cooking, one company stands out for its dedication to bringing the richness of Asian cooking to a global audience: DayDayCook. Founded by the visionary entrepreneur Norma Chu, DayDayCook has rapidly evolved from a humble startup into a multi-brand powerhouse, reshaping the way people around the world perceive and prepare Asian cuisine.
Pharmaceutical Technology
JANUARY 11, 2024
Pauline Frank reflects on her talk at the 2023 CTO Europe conference and highlights some of the key issues in running oncology trials.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharma Times
JANUARY 11, 2024
The diagnostic system can deliver particles to the lungs via aerosol or a nebuliser
Pharmaceutical Technology
JANUARY 11, 2024
Myrobalan Therapeutics has secured $24m in a Series A funding round to develop CNS therapeutics with restorative potential.
Fierce Pharma
JANUARY 11, 2024
With sales declining for aging MS drug Fampyra, Biogen has exercised an option to return licensing rights outside of the U.S. to Acorda Therapeutics.
Pharmaceutical Technology
JANUARY 11, 2024
Mirati filed a marketing authorisation application to the EMA for Krazati for patients within this indication in May 2022.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
pharmaphorum
JANUARY 11, 2024
Stada and Alvotech get EU approval for first biosimilar of Johnson & Johnson's Stelara in psoriasis, psoriatic arthritis and Crohn's disease indications
Pharmaceutical Technology
JANUARY 11, 2024
3M Health Care has received a $34.2m award to improve the treatment of traumatic wounds from point of injury to hospital.
pharmaphorum
JANUARY 11, 2024
In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.
Pharmaceutical Technology
JANUARY 11, 2024
Opnurasib is a small molecule commercialized by Novartis, with a leading Phase III program in Non-Small Cell Lung Cancer.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharma Times
JANUARY 11, 2024
In 2022, around 8% of patients survived 30 days after a cardiac arrest
Pharmaceutical Technology
JANUARY 11, 2024
TSHA-102 is a gene therapy commercialized by Taysha Gene Therapies, with a leading Phase II program in Rett Syndrome.
pharmaphorum
JANUARY 11, 2024
NICE has extended the NHS availability of Pfizer’s COVID-19 drug Paxlovid as millions of doses approach their expiry date
Outsourcing Pharma
JANUARY 11, 2024
Commercial-stage biopharma company, Hutchmed, has good news for adults with primary immune thrombocytopenia (ITP).
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
213 
Let's personalize your content